Clinical Frontiers in Pediatric Neurology

 

Final Program and Abstracts Book (PDF)

 

Thursday, October 17, 2019

8.30 – 9.00	Registration
9.00 – 10.30	Movement disorders Chairperson: Jasna Oražem Mrak, Zvonka Rener-Primec
9.00 – 9.30	Kirsten R. Müller-Vahl Etiology of chronic tic disorders: current state of knowledge
9.30 – 9.50	J Oražem Mrak, D Neubauer Paroxysmal eye movement disorders in children
9.50 – 10.10	D Gosar, S Stropnik, T Meško, P Lešnik-Musek, V Krkoč A Contemporary View of Pediatric Functional Neurological Symptoms: Integrated Etiological Models and their Teatment Implications
10.10 – 10.30	Galina Stevanović Clinical spectrum between epilepsy and movement disorders
10.30 – 10.45	Coffee break
10.45 – 13.20	Epilepsy Chairpersons: Ružica Kravljanac, Mirjana Perković Benedik
10.45 – 11.30	Sameer Zuberi Aetiology & Epidemiology of Epilepsy: a 21st Century Perspective
11.30 – 12.00	Maria Roberta Cilio The new chapter of neonatal epilepsies
12.00 – 12.20	Ružica Kravljanac Status epilepticus as the first epileptic event in children
12.20 – 12.40	Mirjana Perković Benedik Management of Dravet syndrome in Slovenia
12.40 – 13.00	Nina Barišić Sudden unexpected death in epilepsy: Risk factors, mechanisms and prevention
13.00 – 13.20	I Prpić, J Radić Nišević, I Kolić, F Borovečki Genetic testing in children with epilepsy – a Croatian tertiary center experience
13.20 – 14.00	Lunch break
14.00 – 15.45	Open Section Chairperson: Filip Duma
14.00 – 14.20	Tina Vipotnik Diagnostic dilemmas on MR in pseudotumor cerebri
14.20 – 14.50	Daniel Tibussek Complex decision-making in pediatric pseudotumor cerebri
14.50 – 15.10	Slavica Ostojić Clinical presentation of Pompe disease in children
15.10 – 15.30	Nataša Šuštar Clinical characteristics of childhood CNS tumors in Slovenia
15.30 – 15.45	Coffee break
15.45 –	Neuromuscular Diseases Chairpersons: Nina Barišić, Tanja Golli
15.45 – 16.15	Nathalie Goemans Novel therapies in NMD
16.15 – 16.35	T Butenko, T Loboda, T Golli, D Osredkar One year follow-up of children and young adults with SMA treated with nusinersen
16.35 – 16.55	Vedrana Milić Rašić CMT and distal SMA
16.55 – 17.15	Radenka Kuzmanić-Šamija Treatment possibilities in progressed DMD
17.15 – 18.30	Expert Opinion Exchange on SMA treatment with nusinersen: Achievements, Experience and Challenges Speaker from Croatia: Nina Barišić Speaker from Macedonia: Filip Duma Speaker from Montenegro: Nelica Ivanović Radović Speaker from Serbia: Vesna Branković Speaker from Slovenia: Damjan Osredkar
18:30	Social gathering

Friday, October 18, 2019

8.30 – 9.00	Registration
9.00 – 10.40	Open Section Chairperson: Igor Prpić
9.00 – 9.20	Evgen Benedik All you need to know about a diet of children with autism spectrum disorder
9.20 – 9.40	T Golli, Z Rener Primec Neurofibromatosis – an epidemiological overview and therapeutic algorithm
9.40 – 10.00	Barbara Gnidovec Stražišar Sleep related disorders in children
10.00 – 10.20	Maja Đorđević Milošević Neurological manifestations of mitochondrial disorders
10.20 – 10.40	Uroš Krivec Long term monitoring and follow-up of respiratory function in children with NMD
10.40 – 10.55	Coffee break
10.55 – 11.55	Immune-Mediated Neurological Diseases and Congenial Myasthenic Syndromes Chairperson: Vesna Branković
10.55 – 11.15	Neli Bizjak Clinical characteristics of Slovene children with multiple sclerosis
11.15 – 11.35	Vesna Branković Immune mediated cerebellar ataxias in children
11.35 – 11.55	A Troha Gergeli, D Neubauer Congenital myasthenic syndromes
11.55 – 13.00	Lunch break
13.00 – 14.50	New Diagnostic and Treatment Possibilities Chairperson: Radenka Kuzmanić Šamija
13.30 – 13.50	David Neubauer Slovene cohort of patients with refractory epilepsy treated with cannabidiol
13.50 – 14.10	Duma F, Sabolic V, Muaremoska Kanzoska Lj, Alili Ademi L, Milenkova L Practical experiences and perceptions of the Effects of Kanobil Epi as an add-on treatment in refractory epilepsy in children
14.10 – 14.30	Aleš Maver Significance of novel genomic technologies in diagnostics of pediatric neurologic disorders
14.30 – 14.50	Neli Bizjak Gilenya, the first and only oral disease-modifying treatment for children and adolescents with MS Sponsored lecture
14.50 – 15.05	Coffee break
15.05 – 16.00	Thieves Market: Interesting Clinical Cases Chairperson:
	Case #1 by Peter Gradišnik A girl with an atypical from of Dravet Syndrome
	Case #2 by Đaković I, Đuranović V, Fatuta Francheschi D, Jednačak H, Grmoja T, Tripalo Batoš A, Melada A, Sekelj Fureš J, Pejić Roško S, Vulin K. Idiopathic (benign) intracranial hypertension – is it really benign condition?
	Case #3 by Radić Nišević Epileptic encephalopathy caused by a novel heterozygous variant of VARS2 gene mutation
	Case #4 by Sekelj Fureš J, Đuranović V., Lončar L, Pejić Roško S, Đaković I, Vulin K Rare mutation of Congenital Myasthenic Syndrome
	Case #5 by Rener Z Impact of epileptiform activity on cognition
	Case #6 by Pejić Roško S, Đuranović V, Sekelj Fureš J. Lončar L, Đaković I. Vulin K. Opsoclonus-myoclonus Syndrome – a case report
15.25 – 15 – 35	Closing Remarks